On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayJul 31, 2023 11:15 am

GEMXX Corp. (GEMZ) Is ‘One to Watch’

GEMXX has a qualified Regulation A offering in place to raise up to $6 million at $0.40 per share GEMXX’s net income for the three months ended December 31, 2022, increased to $182,992, as compared to $126,360 in the previous quarter The company’s most recent financial results filing continues to report positive net revenues for the year and no long-term debt In March 2023, GEMXX announced it had signed an Ammolite Master Supply Agreement with Canadian Ammolite Gems by Kenneth Bradley GEMXX (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources,…

Continue Reading

MondayJul 31, 2023 10:30 am

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Reports ‘Outstanding’ Results from Midlothian Project Drilling

IEA projects EV sales to grow by 35% this year to reach 14 million Drilling results confirm Midlothian as a “significant discovery,” states CEO Testing was comprised of four drillholes, which were completed during winter 2023 With the electric vehicle (“EV”) market growing — and projected to increase even more in the coming years (https://nnw.fm/eN75F) — demand for EV components, including nickel, is growing as well. Nickel is an essential material used in many EV batteries, and Canada Nickel Company (TSX.V: CNC) (OTCQX: CNIKF) is committed to increase its production to meet the growing demand. As evidence of that commitment,…

Continue Reading

MondayJul 31, 2023 9:45 am

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) Completes Surveys at Graphite Project as U.S. and Canada Align for Ex-China Supply Chain

North America is actively developing domestic graphite supply as part of the EV revolution to reduce dependence upon China, the world’s top supplier Reflex Advanced Materials is executing on a “mine-to-market” strategy where it will have integrated domestic operations to supply high purity natural graphite for hi-tech applications, including EV batteries Reflex recently completed a TDEM and magnetic helicopter survey on its Ruby Graphite property, which will deliver additional data to map the depth and extent of mineral deposits planned to be drilled this summer As it goes, China is currently the dominant player in the electric vehicle supply chain,…

Continue Reading

MondayJul 31, 2023 9:00 am

Sharing Services Global Corp. (SHRG) Subsidiary Unveils Two New Exclusive Product Offerings

The Happy Co. has unveiled Tropical Twist, a cool and refreshing addition to its PerX energy drink line PerX beverages are formulated to provide natural appetite control while boosting metabolism and energy The company also launched Probio8, a new probiotic dietary supplement product Sharing Services Global’s (OTCQB: SHRG) wholly owned subsidiary, The Happy Co., has recently added to its exclusive product line. The company unveiled a new limited-time seasonal flavor for its popular energy drink PerX (https://nnw.fm/v27hf) and also launched a new probiotic dietary supplement product called Probio8 (https://nnw.fm/w3rYF). The Happy Co. is a leading producer and distributor of nootropic,…

Continue Reading

FridayJul 28, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Secures Exclusivity for REQORSA(R)-Keytruda(R) Drug Combination in China with Chinese Patent

Genprex recently received a patent in China covering the use of its drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat cancers The REQORSA-Keytruda drug combination is the subject of Genprex’s ongoing Acclaim-2 clinical trial, which targets patients with advanced, metastatic non-small cell lung cancer whose disease progressed after treatment with Keytruda The company has received patent protection for the REQORSA-Keytruda drug combination in the U.S., Japan, Australia, Russia, Mexico, and China, meaning the company has secured exclusivity in many of the largest markets The granted patents, three Fast Track Designations, and positive preclinical…

Continue Reading

FridayJul 28, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Newly Granted Patent for DehydraTECH(TM)–Nicotine by United States Patent and Trademark Office

Lexaria’s new patent includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine citrate, nicotine polacrilex, and many others, for use in sublingual delivery formats like oral pouches The global oral nicotine pouch market was valued at $4.69 billion in 2022 and is expected to grow to $11.91 billion by 2029, driven by the growing ban on e-cigarettes worldwide The white pouch category is one of the fastest-growing, tobacco-free alternatives to smoking and vaping – growing at a CAGR of 13.4% Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, has announced that the United…

Continue Reading

ThursdayJul 27, 2023 11:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Keeping a Close Eye on FMCSA Speed Limiter Rule, Amid Growing Debate and Displeasure from OOIDA

The FMCSA (Federal Motor Carrier Safety Administration) proposed a rule mandating speed limiters for most commercial vehicles The ATA has supported the move, while OOIDA (Owner Operator Independent Drivers Association) has opposed it, terming it as an attempt to eliminate one of the few advantages they enjoy over big business The FMCSA is yet to communicate its decision on the matter, pending its review of over 15,000 comments on the issue Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility, and simplicity, is…

Continue Reading

ThursdayJul 27, 2023 9:00 am

Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Poised to Benefit as Silver Stocks Slip into Deep Deficit

Global ambitions to achieve net zero status will necessitate a near tripling in annual clean energy investment Silver has emerged as a critical component of clean energy infrastructure due to its exceptional electric and thermal conductivity Nevertheless, a decrease in global silver production coupled with rising demand has left the precious metal in deficit – with the market undersupplied by nearly 238mn tonnes in 2022 Eloro Resources’ Iska Iska deposit may be poised to emerge as a rare greenfield silver project with the company set to publish its inaugural NI 43-101 compliant mineral resource estimate Global warming has become an…

Continue Reading

WednesdayJul 26, 2023 10:30 am

DGE’s 3rd Diversity, Equity & Inclusion for Pharma & Healthcare Summit

DGE invites life science Diversity, Equity & Inclusion (“DEI”) practitioners, health equity advocates, HR executives, and health policy leaders, to attend the 3rd Advancing Diversity, Equity & Inclusion in Pharma & Healthcare Summit to be held at the Hyatt Bellevue, Philadelphia, PA, on September 19-20, 2023. The industry’s leading event will focus on putting developing policies into practices including novel case studies and sessions on important areas. The leading DEI event for Pharma & Healthcare serves as a dynamic platform for industry leaders, advocates, practitioners and influencers to convene, work toward common goals and drive the life science ecosystem toward…

Continue Reading

WednesdayJul 26, 2023 9:45 am

M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, was featured in a recent analyst report reiterating a Buy recommendation and a $70 target price The report discussed Eli Lilly’s announcement of a definitive agreement to acquire DICE Therapeutics for approximately $2.4 billion as evidence of the potential value of BiondVax in this segment of the therapeutics market DICE Therapeutics is currently evaluating its lead drug candidate, DC-806, an oral IL-17 inhibitor, in a Phase II trial, with early-stage results from the Phase I study showing a near-44% reduction in Psoriasis Area and Severity Index The…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217